ORMP
Oramed Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.01
+1.62%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
55.1%
Return on equity
47.3%
Return on assets
-4.6%
Return on invested capital
0.00x
Asset turnover
-$5.6M
Cash from operations
$1.22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026